These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34181952)

  • 1. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
    Sweatt AJ; Miyagawa K; Rhodes CJ; Taylor S; Del Rosario PA; Hsi A; Haddad F; Spiekerkoetter E; Bental-Roof M; Bland RD; Swietlik EM; Gräf S; Wilkins MR; Morrell NW; Nicolls MR; Rabinovitch M; Zamanian RT
    Chest; 2021 Oct; 160(4):1442-1458. PubMed ID: 34181952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
    Nickel NP; Spiekerkoetter E; Gu M; Li CG; Li H; Kaschwich M; Diebold I; Hennigs JK; Kim KY; Miyagawa K; Wang L; Cao A; Sa S; Jiang X; Stockstill RW; Nicolls MR; Zamanian RT; Bland RD; Rabinovitch M
    Am J Respir Crit Care Med; 2015 Jun; 191(11):1273-86. PubMed ID: 25853696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
    Griffiths M; Yang J; Simpson CE; Vaidya D; Nies M; Brandal S; Damico R; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Rosenzweig EB; Hirsch R; Yung D; Nichols WC; Everett AD
    Chest; 2021 Jul; 160(1):297-306. PubMed ID: 33609516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
    Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
    Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Didriksen H; Molberg Ø; Fretheim H; Gude E; Jordan S; Brunborg C; Palchevskiy V; Garen T; Midtvedt Ø; Andreassen AK; Distler O; Belperio J; Hoffmann-Vold AM
    Arthritis Rheumatol; 2021 Jul; 73(7):1277-1287. PubMed ID: 33497027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma Pim-1 and its clinical significance in patients with pulmonary arterial hypertension.
    Zhu T; Luo J; Wang Y; Xiong X; Sheng B; Yang X; Ndongala NAMT; Li J
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):752-760. PubMed ID: 31066078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development.
    Wang Z; Chen F; Zhai R; Zhang L; Su L; Lin X; Thompson T; Christiani DC
    PLoS One; 2009; 4(2):e4380. PubMed ID: 19197381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
    Prins KW; Kalra R; Rose L; Assad TR; Archer SL; Bajaj NS; Weir EK; Prisco SZ; Pritzker M; Lutsey PL; Brittain EL; Thenappan T
    J Am Heart Assoc; 2020 Mar; 9(5):e015221. PubMed ID: 32079477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
    Simpson CE; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies MK; Vaidya RD; Brandal S; Pauciulo MW; Austin ED; Ivy DD; Nichols WC; Everett AD
    Chest; 2020 Jun; 157(6):1606-1616. PubMed ID: 31987881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.
    Yang J; Nies MK; Fu Z; Damico R; Korley FK; Hassoun PM; Ivy DD; Austin ED; Everett AD
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1264-1272. PubMed ID: 27254543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
    Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S
    J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.
    Taylor S; Isobe S; Cao A; Contrepois K; Benayoun BA; Jiang L; Wang L; Melemenidis S; Ozen MO; Otsuki S; Shinohara T; Sweatt AJ; Kaplan J; Moonen JR; Marciano DP; Gu M; Miyagawa K; Hayes B; Sierra RG; Kupitz CJ; Del Rosario PA; Hsi A; Thompson AAR; Ariza ME; Demirci U; Zamanian RT; Haddad F; Nicolls MR; Snyder MP; Rabinovitch M
    Am J Respir Crit Care Med; 2022 Oct; 206(8):1019-1034. PubMed ID: 35696338
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.
    Sweatt AJ; Hedlin HK; Balasubramanian V; Hsi A; Blum LK; Robinson WH; Haddad F; Hickey PM; Condliffe R; Lawrie A; Nicolls MR; Rabinovitch M; Khatri P; Zamanian RT
    Circ Res; 2019 Mar; 124(6):904-919. PubMed ID: 30661465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome: A Multicenter Survival and Longitudinal Prospective Observation Study.
    Wang T; Zhu Z; Liu Z; Yi L; Yang Z; Bian W; Chen W; Wang S; Li G; Li A; Martin GS; Zhu X
    Shock; 2017 Aug; 48(2):168-174. PubMed ID: 28187039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children.
    Said F; Haarman MG; Roofthooft MTR; Hillege HL; Ploegstra MJ; Berger RMF
    J Pediatr; 2020 May; 220():139-145. PubMed ID: 32113658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.